Arnold Schwartz, Ph.D. - Publications

Institute of Molecular Pharmacology and Biophysics University of Cincinnati, Cincinnati, OH 

240 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Mastrolia V, Flucher SM, Obermair GJ, Drach M, Hofer H, Renström E, Schwartz A, Striessnig J, Flucher BE, Tuluc P. Loss of α2δ-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes. Diabetes. PMID 28115397 DOI: 10.2337/Db16-0336  0.347
2016 Margas W, Ferron L, Nieto-Rostro M, Schwartz A, Dolphin AC. Effect of knockout of α2δ-1 on action potentials in mouse sensory neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 371. PMID 27377724 DOI: 10.1098/Rstb.2015.0430  0.41
2013 Patel R, Bauer CS, Nieto-Rostro M, Margas W, Ferron L, Chaggar K, Crews K, Ramirez JD, Bennett DL, Schwartz A, Dickenson AH, Dolphin AC. α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16412-26. PMID 24133248 DOI: 10.1523/Jneurosci.1026-13.2013  0.306
2011 Petrashevskaya NN, Ishii M, D'Souza K, Koch SE, Fuller-Bicer GA, Schwartz A. Presynaptic stimulus-release and postsynaptic compensatory changes in mice lacking the N-type calcium channel α(1B)-subunit. Autonomic Neuroscience : Basic & Clinical. 160: 9-15. PMID 20937570 DOI: 10.1016/J.Autneu.2010.09.007  0.392
2009 Nakayama H, Bodi I, Correll RN, Chen X, Lorenz J, Houser SR, Robbins J, Schwartz A, Molkentin JD. alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. The Journal of Clinical Investigation. 119: 3787-96. PMID 19920353 DOI: 10.1172/Jci39724  0.31
2009 Beetz N, Hein L, Meszaros J, Gilsbach R, Barreto F, Meissner M, Hoppe UC, Schwartz A, Herzig S, Matthes J. Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice. Cardiovascular Research. 84: 396-406. PMID 19620129 DOI: 10.1093/Cvr/Cvp251  0.457
2009 Fuller-Bicer GA, Varadi G, Koch SE, Ishii M, Bodi I, Kadeer N, Muth JN, Mikala G, Petrashevskaya NN, Jordan MA, Zhang SP, Qin N, Flores CM, Isaacsohn I, Varadi M, ... ... Schwartz A, et al. Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit. American Journal of Physiology. Heart and Circulatory Physiology. 297: H117-24. PMID 19429829 DOI: 10.1152/Ajpheart.00122.2009  0.795
2009 Jagatheesan G, Rajan S, Schulz EM, Ahmed RP, Petrashevskaya N, Schwartz A, Boivin GP, Arteaga GM, Wang T, Wang YG, Ashraf M, Liggett SB, Lorenz J, Solaro RJ, Wieczorek DF. An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity. American Journal of Physiology. Heart and Circulatory Physiology. 297: H181-90. PMID 19429821 DOI: 10.1152/Ajpheart.00329.2008  0.41
2009 Wang S, Ziman B, Bodi I, Rubio M, Zhou YY, D'Souza K, Bishopric NH, Schwartz A, Lakatta EG. Dilated cardiomyopathy with increased SR Ca2+ loading preceded by a hypercontractile state and diastolic failure in the alpha(1C)TG mouse. Plos One. 4: e4133. PMID 19125184 DOI: 10.1371/Journal.Pone.0004133  0.632
2009 Jagatheesan G, Schulz EM, Ahmed RP, Petrashevskaya N, Schwartz A, Boivin GP, Arteaga GM, Liggett SB, Solaro RJ, Wieczorek DF. An Internal Domain of Beta Tropomyosin Increases Myofilament Calcium Sensitivity Biophysical Journal. 96: 504a. DOI: 10.1016/J.Bpj.2008.12.2597  0.402
2008 Mandel F, Kranias EG, Schwartz A. The effect of cAMP-dependent protein kinase phosphorylation on the external Ca2+ binding sites of cardiac sarcoplasmic reticulum. Journal of Bioenergetics and Biomembranes. 15: 179-94. PMID 18251105 DOI: 10.1007/Bf00743939  0.413
2007 Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Arteaga GM, Solaro RJ, Liggett SB, Wieczorek DF. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. American Journal of Physiology. Heart and Circulatory Physiology. 293: H949-58. PMID 17416600 DOI: 10.1152/Ajpheart.01341.2006  0.38
2007 Hullin R, Matthes J, von Vietinghoff S, Bodi I, Rubio M, D'Souza K, Friedrich Khan I, Rottländer D, Hoppe UC, Mohacsi P, Schmitteckert E, Gilsbach R, Bünemann M, Hein L, Schwartz A, et al. Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+ channels leads to single-channel activity characteristic of heart failure. Plos One. 2: e292. PMID 17356701 DOI: 10.1371/Journal.Pone.0000292  0.631
2007 Herzig S, Khan IF, Gründemann D, Matthes J, Ludwig A, Michels G, Hoppe UC, Chaudhuri D, Schwartz A, Yue DT, Hullin R. Mechanism of Ca(v)1.2 channel modulation by the amino terminus of cardiac beta2-subunits. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1527-38. PMID 17289923 DOI: 10.1096/Fj.06-7377Com  0.307
2007 Bodi I, D'Souza K, Liggett SB, Schwartz A. WITHDRAWN: Enhanced Ca2+ transient & cell contractility is associated with decreased Cx43 in β1-ARG389 mice Journal of Molecular and Cellular Cardiology. DOI: 10.1016/J.Yjmcc.2007.03.853  0.325
2007 Bodi I, D'Souza K, Liggett S, Schwartz A. Enhanced Ca2+ transient and cell contractility is associated with decreased Cx43 in β1-ARG389 mice Journal of Molecular and Cellular Cardiology. 42: S110. DOI: 10.1016/J.Yjmcc.2007.03.249  0.324
2007 Bodi I, D'Souza K, Rubio M, Nicolaou S, Fuller G, Conforti L, Molkentin J, Schwartz A. Calcineurin Aβ null partially rescues impaired cardiac function in targeted overexpression of L-LVDCC α1C Journal of Molecular and Cellular Cardiology. 42: S37. DOI: 10.1016/J.Yjmcc.2007.03.104  0.555
2006 Rajan S, Williams SS, Jagatheesan G, Ahmed RP, Fuller-Bicer G, Schwartz A, Aronow BJ, Wieczorek DF. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy. Physiological Genomics. 27: 309-17. PMID 16882888 DOI: 10.1152/Physiolgenomics.00072.2006  0.328
2006 Babu GJ, Bhupathy P, Petrashevskaya NN, Wang H, Raman S, Wheeler D, Jagatheesan G, Wieczorek D, Schwartz A, Janssen PM, Ziolo MT, Periasamy M. Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility. The Journal of Biological Chemistry. 281: 3972-9. PMID 16365042 DOI: 10.1074/Jbc.M508998200  0.337
2005 Rubio M, Bodi I, Fuller-Bicer GA, Hahn HS, Periasamy M, Schwartz A. Sarcoplasmic reticulum adenosine triphosphatase overexpression in the L-type Ca2+ channel mouse results in cardiomyopathy and Ca2+ -induced arrhythmogenesis. Journal of Cardiovascular Pharmacology and Therapeutics. 10: 235-49. PMID 16382260 DOI: 10.1177/107424840501000404  0.669
2005 Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A. The L-type calcium channel in the heart: the beat goes on. The Journal of Clinical Investigation. 115: 3306-17. PMID 16322774 DOI: 10.1172/Jci27167  0.454
2004 Lebeche D, Kaprielian R, del Monte F, Tomaselli G, Gwathmey JK, Schwartz A, Hajjar RJ. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 110: 3435-43. PMID 15557376 DOI: 10.1161/01.Cir.0000148176.33730.3F  0.336
2004 Petrashevskaya NN, Bodi I, Koch SE, Akhter SA, Schwartz A. Effects of alpha1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression. Cardiovascular Research. 63: 561-72. PMID 15276482 DOI: 10.1016/J.Cardiores.2004.01.026  0.412
2004 Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Arteaga G, de Tombe PP, Solaro RJ, Wieczorek DF. Physiological significance of troponin T binding domains in striated muscle tropomyosin. American Journal of Physiology. Heart and Circulatory Physiology. 287: H1484-94. PMID 15191887 DOI: 10.1152/Ajpheart.01112.2003  0.405
2004 Scragg JL, Fearon IM, Ball SG, Schwartz A, Varadi G, Peers C. Analysis of oxygen-sensitive human cardiac L-type Ca2+ channel alpha1C subunit (hHT Isoform). Methods in Enzymology. 381: 290-302. PMID 15063682 DOI: 10.1016/S0076-6879(04)81020-6  0.328
2004 Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nature Medicine. 10: 248-54. PMID 14966518 DOI: 10.1038/Nm1000  0.423
2004 Matthes J, Jäger A, Handrock R, Groner F, Mehlhorn U, Schwinger RH, Varadi G, Schwartz A, Herzig S. Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine. Journal of Molecular and Cellular Cardiology. 36: 241-55. PMID 14871552 DOI: 10.1016/J.Yjmcc.2003.11.013  0.461
2004 Groner F, Rubio M, Schulte-Euler P, Matthes J, Khan IF, Bodi I, Koch SE, Schwartz A, Herzig S. Single-channel gating and regulation of human L-type calcium channels in cardiomyocytes of transgenic mice. Biochemical and Biophysical Research Communications. 314: 878-84. PMID 14741718 DOI: 10.1016/J.Bbrc.2003.12.174  0.664
2003 Hahn HS, Marreez Y, Odley A, Sterbling A, Yussman MG, Hilty KC, Bodi I, Liggett SB, Schwartz A, Dorn GW. Protein kinase Calpha negatively regulates systolic and diastolic function in pathological hypertrophy. Circulation Research. 93: 1111-9. PMID 14605019 DOI: 10.1161/01.Res.0000105087.79373.17  0.37
2003 Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nature Medicine. 9: 1300-5. PMID 14502278 DOI: 10.1038/Nm930  0.363
2003 Mikala G, Bodi I, Klockner U, Varadi M, Varadi G, Koch SE, Schwartz A. Characterization of auto-regulation of the human cardiac alpha1 subunit of the L-type calcium channel: importance of the C-terminus. Molecular and Cellular Biochemistry. 250: 81-9. PMID 12962146 DOI: 10.1023/A:1024910605389  0.389
2003 Bodi I, Muth JN, Hahn HS, Petrashevskaya NN, Rubio M, Koch SE, Varadi G, Schwartz A. Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: complex nature of K+ current changes and action potential duration. Journal of the American College of Cardiology. 41: 1611-22. PMID 12742305 DOI: 10.1016/S0735-1097(03)00244-4  0.792
2003 Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Vahebi S, DeTombe P, Solaro RJ, Labitzke E, Hilliard G, Wieczorek DF. Functional importance of the carboxyl-terminal region of striated muscle tropomyosin. The Journal of Biological Chemistry. 278: 23204-11. PMID 12690096 DOI: 10.1074/Jbc.M303073200  0.403
2002 Petrashevskaya NN, Koch SE, Bodi I, Schwartz A. Calcium cycling, historic overview and perspectives. Role for autonomic nervous system regulation. Journal of Molecular and Cellular Cardiology. 34: 885-96. PMID 12234761 DOI: 10.1006/Jmcc.2002.2033  0.422
2002 Petrashevskaya NN, Bodi I, Rubio M, Molkentin JD, Schwartz A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovascular Research. 54: 117-32. PMID 12062368 DOI: 10.1016/S0008-6363(02)00241-9  0.643
2002 Serikov V, Bodi I, Koch SE, Muth JN, Mikala G, Martinov SG, Haase H, Schwartz A. Mice with cardiac-specific sequestration of the beta-subunit of the L-type calcium channel. Biochemical and Biophysical Research Communications. 293: 1405-11. PMID 12054671 DOI: 10.1016/S0006-291X(02)00396-0  0.783
2002 Bodi I, Koch SE, Yamaguchi H, Szigeti GP, Schwartz A, Varadi G. The role of region IVS5 of the human cardiac calcium channel in establishing inactivated channel conformation: use-dependent block by benzothiazepines. The Journal of Biological Chemistry. 277: 20651-9. PMID 11912204 DOI: 10.1074/Jbc.M200752200  0.432
2002 Song LS, Guia A, Muth JN, Rubio M, Wang SQ, Xiao RP, Josephson IR, Lakatta EG, Schwartz A, Cheng H. Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel. Circulation Research. 90: 174-81. PMID 11834710 DOI: 10.1161/Hh0202.103230  0.784
2001 Muth JN, Varadi G, Schwartz A. Use of transgenic mice to study voltage-dependent Ca2+ channels. Trends in Pharmacological Sciences. 22: 526-32. PMID 11583810 DOI: 10.1016/S0165-6147(00)01797-1  0.799
2001 Chang W, Pratt SA, Chen TH, Tu CL, Mikala G, Schwartz A, Shoback D. Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits American Journal of Physiology - Endocrinology and Metabolism. 281: E180-E189. PMID 11404236 DOI: 10.1152/Ajpendo.2001.281.1.E180  0.453
2001 Schwartz A, Petrashevskaya NN. The importance of calcium in interpretation of NaK-ATPase isoform function in the mouse heart Cardiovascular Research. 51: 9-12. PMID 11399242 DOI: 10.1016/S0008-6363(01)00336-4  0.415
2001 Mori T, Takase H, Toide K, Hirano T, Kambe T, Nakayama N, Schwartz A. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation Cardiovascular Drug Reviews. 19: 1-8. PMID 11314598 DOI: 10.1111/J.1527-3466.2001.Tb00179.X  0.357
2001 Serikov VB, Petrashevskaya NN, Canning AM, Schwartz A. Reduction of [Ca2+]i restores uncoupled β-adrenergic signaling in isolated perfused transgenic mouse hearts Circulation Research. 88: 9-11. PMID 11139467 DOI: 10.1161/01.Res.88.1.9  0.473
2001 Muth JN, Bodi I, Lewis W, Varadi G, Schwartz A. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha. Circulation. 103: 140-7. PMID 11136699 DOI: 10.1161/01.CIR.103.1.140  0.807
2000 Koch SE, Bodi I, Schwartz A, Varadi G. Architecture of Ca2+ channel pore-lining segments revealed by covalent modification of substituted cysteines Journal of Biological Chemistry. 275: 34493-34500. PMID 10950957 DOI: 10.1074/Jbc.M005569200  0.414
1999 Schwartz A. Inotropy, calcium, and heart failure: A personal perspective American Journal of Cardiology. 83: 86H-88H. PMID 10750594 DOI: 10.1016/S0002-9149(99)00267-2  0.316
1999 Muth JN, Yamaguchi H, Mikala G, Grupp IL, Lewis W, Cheng H, Song LS, Lakatta EG, Varadi G, Schwartz A. Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage-dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction. The Journal of Biological Chemistry. 274: 21503-6. PMID 10419451 DOI: 10.1074/Jbc.274.31.21503  0.819
1999 Strobeck MW, Okuda M, Yamaguchi H, Schwartz A, Fukasawa K. Morphological transformation induced by activation of the mitogen-activated protein kinase pathway requires suppression of the T-type Ca2+ channel. The Journal of Biological Chemistry. 274: 15694-700. PMID 10336467 DOI: 10.1074/Jbc.274.22.15694  0.372
1999 Motoike HK, Bodi I, Nakayama H, Schwartz A, Varadi G. A region in IVS5 of the human cardiac L-type calcium channel is required for the use-dependent block by phenylalkylamines and benzothiazepines Journal of Biological Chemistry. 274: 9409-9420. PMID 10092621 DOI: 10.1074/Jbc.274.14.9409  0.419
1999 Yamaguchi H, Muth JN, Varadi M, Schwartz A, Varadi G. Critical role of conserved proline residues in the transmembrane segment 4 voltage sensor function and in the gating of L-type calcium channels. Proceedings of the National Academy of Sciences of the United States of America. 96: 1357-62. PMID 9990028 DOI: 10.1073/Pnas.96.4.1357  0.779
1998 Ii N, Kuniyasu A, Kawahara K, Shibano T, Schwartz A, Nakayama H. Photochemical localization of the semotiadil binding region within the cardiac Ca2+ channel α1 subunit. Comparison with the skeletal muscle counterpart Febs Letters. 441: 83-87. PMID 9877170 DOI: 10.1016/S0014-5793(98)01536-1  0.432
1998 Mikala G, Klöckner U, Varadi M, Eisfeld J, Schwartz A, Varadi G. cAMP-dependent phosphorylation sites and macroscopic activity of recombinant cardiac L-type calcium channels Molecular and Cellular Biochemistry. 185: 95-109. PMID 9746216 DOI: 10.1023/A:1006878106672  0.477
1998 Yamaguchi H, Hara M, Strobeck M, Fukasawa K, Schwartz A, Varadi G. Multiple modulation pathways of calcium channel activity by a beta subunit. Direct evidence of beta subunit participation in membrane trafficking of the alpha1C subunit. The Journal of Biological Chemistry. 273: 19348-56. PMID 9668125 DOI: 10.1074/Jbc.273.30.19348  0.381
1998 Kuniyasu A, Itagaki K, Shibano T, Iino M, Kraft G, Schwartz A, Nakayama H. Photochemical identification of Transmembrane segment IVS6 as the binding region of semotiadil, a new modulator for the L-type voltage- dependent Ca2+ channel Journal of Biological Chemistry. 273: 4635-4641. PMID 9468522 DOI: 10.1074/Jbc.273.8.4635  0.414
1997 Bodi I, Yamaguchi H, Hara M, He M, Schwartz A, Varadi G. Molecular studies on the voltage dependence of dihydropyridine action on L-type Ca2+ channels Journal of Biological Chemistry. 272: 24952-24960. PMID 9312099 DOI: 10.1074/Jbc.272.40.24952  0.385
1997 Kobayashi T, Strobeck M, Schwartz A, Mori Y. Inhibitory effects of a new neuroprotective diltiazem analogue, T-477, on cloned brain Ca2+ channels expressed in Xenopus oocytes European Journal of Pharmacology. 332: 313-320. PMID 9300266 DOI: 10.1016/S0014-2999(97)01092-3  0.404
1997 Fearon IM, Palmer ACV, Balmforth AJ, Ball SG, Mikala G, Schwartz A, Peers C. Hypoxia inhibits the recombinant α(1C) subunit of the human cardiac L-type Ca2+ channel Journal of Physiology. 500: 551-556. PMID 9161974 DOI: 10.1113/Jphysiol.1997.Sp022041  0.351
1997 Bahinski A, Yatani A, Mikala G, Tang S, Yamamoto S, Schwartz A. Charged amino acids near the pore entrance influence ion-conduction of a human L-type cardiac calcium channel Molecular and Cellular Biochemistry. 166: 125-134. PMID 9046029 DOI: 10.1023/A:1006847632410  0.431
1997 Eisfeld J, Mikala G, Varadi G, Schwartz A, Klöckner U. Inhibition of cloned human L-type cardiac calcium channels by 2,3-butanedione monoxime does not require PKA-Dependent phosphorylation sites Biochemical and Biophysical Research Communications. 230: 489-492. PMID 9015346 DOI: 10.1006/Bbrc.1996.5852  0.452
1997 He M, Bodi I, Mikala G, Schwartz A. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study Journal of Biological Chemistry. 272: 2629-2633. PMID 9006896 DOI: 10.1074/Jbc.272.5.2629  0.41
1997 Klöckner U, Mikala G, Eisfeld J, Iles DE, Strobeck M, Mershon JL, Schwartz A, Varadi G. Properties of three COOH-terminal splice variants of a human cardiac L-type Ca2+-channel α1-subunit American Journal of Physiology - Heart and Circulatory Physiology. 41: H1372-H1381.  0.306
1996 Dhar PK, Grupp IL, Schwartz A, Grupp G, Matlib MA. Reduction of Carnitine Content by Inhibition of Its Biosynthesis Results in Protection of Isolated Guinea Pig Hearts Against Hypoxic Damage. Journal of Cardiovascular Pharmacology and Therapeutics. 1: 235-242. PMID 10684422 DOI: 10.1053/Jcpt.1996.0235  0.321
1996 Lathrop DA, Nánási PP, Varró A, Schwartz A. Comparison of the Electromechanical Effects of Vesnarinone and Amrinone in Isolated Dog Purkinje Strands and Ventricular Trabeculae. Journal of Cardiovascular Pharmacology and Therapeutics. 1: 133-140. PMID 10684410 DOI: 10.1177/107424849600100207  0.319
1996 Mori Y, Mikala G, Varadi G, Kobayashi T, Koch S, Wakamori M, Schwartz A. Molecular pharmacology of voltage-dependent calcium channels Japanese Journal of Pharmacology. 72: 83-109. PMID 8912911 DOI: 10.1254/Jjp.72.83  0.422
1996 Klöckner U, Mikala G, Schwartz A, Varadi G. Molecular studies of the asymmetric pore structure of the human cardiac voltage-dependent Ca2+ channel. Conserved residue, Glu-1086, regulates proton-dependent ion permeation Journal of Biological Chemistry. 271: 22293-22296. PMID 8798385 DOI: 10.1074/Jbc.271.37.22293  0.404
1996 Eisfeld J, Mikala G, Schwartz A, Varadi G, Klöckner U. Lack of involvement of protein kinase A phosphorylation in voltage-dependent facilitation of the activity of human cardiac L-type calcium channels Biochemical and Biophysical Research Communications. 221: 446-453. PMID 8619875 DOI: 10.1006/Bbrc.1996.0615  0.432
1995 Varadi G, Mori Y, Mikala G, Schwartz A. Molecular determinants of Ca2+ channel function and drug action Trends in Pharmacological Sciences. 16: 43-49. PMID 7762082 DOI: 10.1016/S0165-6147(00)88977-4  0.457
1995 Varadi G, Mikala G, Lory P, Varadi M, Drouet B, Pinçon-Raymond M, Schwartz A. Endogenous cardiac Ca2+ channels do not overcome the E-C coupling defect in immortalized dysgenic muscle cells: evidence for a missing link. Febs Letters. 368: 405-10. PMID 7635187 DOI: 10.1016/0014-5793(95)00697-8  0.614
1995 Klöckner U, Mikala G, Varadi M, Varadi G, Schwartz A. Involvement of the carboxyl-terminal region of the α1 subunit in voltage-dependent inactivation of cardiac calcium channels Journal of Biological Chemistry. 270: 17306-17310. PMID 7615531 DOI: 10.1074/Jbc.270.29.17306  0.441
1995 Krizanova O, Varadi M, Schwartz A, Varadi G. Coexpression of skeletal muscle voltage-dependent calcium channel α1 and β cDNAs in mouse Ltk- cells increases the amount of α1 protein in the cell membrane Biochemical and Biophysical Research Communications. 211: 921-927. PMID 7598723 DOI: 10.1006/Bbrc.1995.1900  0.39
1994 Schwartz A. Molecular studies of the calcium antagonist binding site on calcium channels The American Journal of Cardiology. 73: B12-B14. PMID 8141073 DOI: 10.1016/0002-9149(94)90259-3  0.402
1994 Yatani A, Bahinski A, Mikala G, Yamamoto S, Schwartz A. Single amino acid substitutions within the ion permeation pathway alter single-channel conductance of the human L-type cardiac Ca2+ channel Circulation Research. 75: 315-323. PMID 8033343 DOI: 10.1161/01.Res.75.2.315  0.428
1994 Peng M, Fan H, Kirley TL, Caswell AH, Schwartz A. Structural diversity of triadin in skeletal muscle and evidence of its existence in heart Febs Letters. 348: 17-20. PMID 8026576 DOI: 10.1016/0014-5793(94)00556-7  0.35
1994 Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T. The naming of voltage-gated calcium channels. Neuron. 13: 505-6. PMID 7917287 DOI: 10.1016/0896-6273(94)90021-3  0.384
1994 Yatani A, Bahinski A, Wakamori M, Tang S, Mori Y, Kobayashi T, Schwartz A. Alteration of channel characteristics by exchange of pore-forming regions between two structurally related Ca2+ Channels Molecular and Cellular Biochemistry. 140: 93-102. PMID 7898492 DOI: 10.1007/Bf00926748  0.431
1994 Mershon JL, Mikala G, Schwartz A. Changes in the expression of the L-type voltage-dependent calcium channel during pregnancy and parturition in the rat Biology of Reproduction. 51: 993-999. PMID 7849200 DOI: 10.1095/Biolreprod51.5.993  0.392
1994 Wakamori M, Niidome T, Furutama D, Furuichi T, Mikoshiba K, Fujita Y, Tanaka I, Katayama K, Yatani A, Schwartz A, Mori Y. Distinctive functional properties of the neuronal BII (class E) calcium channel Receptors and Channels. 2: 303-314. PMID 7719708  0.303
1994 Baik YH, French JF, Schwartz A, Rapoport RM. Dihydropyridine ca2+ channel agonists and antagonists potentiate ultraviolet light-induced relaxation through cyclic gmp formation in porcine coronary artery Journal of Cardiovascular Pharmacology. 23: 785-791. PMID 7521462 DOI: 10.1097/00005344-199405000-00014  0.363
1993 Kalasz H, Watanabe T, Yabana H, Itagaki K, Naito K, Nakayama H, Schwartz A, Vaghy PL. Identification of 1,4-dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L-type calcium channel Febs Letters. 331: 177-181. PMID 8405401 DOI: 10.1016/0014-5793(93)80321-K  0.411
1993 Schultz D, Mikala G, Yatani A, Engle DB, Iles DE, Segers B, Sinke RJ, Weghuis DO, Klöckner U, Wakamori M, Wang JJ, Melvin D, Varadi G, Schwartz A. Cloning, chromosomal localization, and functional expression of the α1 subunit of the L-type voltage-dependent calcium channel from normal human heart Proceedings of the National Academy of Sciences of the United States of America. 90: 6228-6232. PMID 8392192 DOI: 10.1073/PNAS.90.13.6228  0.317
1993 Lory P, Varadi G, Slish DF, Varadi M, Schwartz A. Characterization of beta subunit modulation of a rabbit cardiac L-type Ca2+ channel alpha 1 subunit as expressed in mouse L cells. Febs Letters. 315: 167-72. PMID 8380271 DOI: 10.1016/0014-5793(93)81156-T  0.619
1993 Tang S, Yatan A, Bahinski A, Mori Y, Schwartz A. Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action Neuron. 11: 1013-1021. PMID 8274273 DOI: 10.1016/0896-6273(93)90215-D  0.439
1993 Wakamori M, Mikala G, Schwartz A, Yatani A. Single-Channel Analysis of a Cloned Human Heart L-Type Ca2+ Channel α1 Subunit and the Effects of a Cardiac β Subunit Biochemical and Biophysical Research Communications. 196: 1170-1176. PMID 8250875 DOI: 10.1006/Bbrc.1993.2374  0.455
1993 Watanabe T, Kalasz H, Yabana H, Kuniyasu A, Mershon J, Itagaki K, Vaghy PL, Naito K, Nakayama H, Schwartz A. Azidobutyryl clentiazem, a new photoactivatable diltiazem analog, labels benzothiazepine binding sites in the α1 subunit of the skeletal muscle calcium channel Febs Letters. 334: 261-264. PMID 8243628 DOI: 10.1016/0014-5793(93)80690-V  0.368
1993 Lathrop DA, Nánási PP, Schwartz A, Varró A. Ionic basis for OPC-8212-induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes European Journal of Pharmacology. 240: 127-137. PMID 8243533 DOI: 10.1016/0014-2999(93)90890-T  0.389
1993 Collin T, Wang JJ, Nargeot J, Schwartz A. Molecular cloning of three isoforms of the L-type voltage-dependent calcium channel beta subunit from normal human heart. Circulation Research. 72: 1337-44. PMID 7916667 DOI: 10.1161/01.Res.72.6.1337  0.331
1993 Mikala G, Bahinski A, Yatani A, Tang S, Schwartz A. Differential contribution by conserved glutamate residues to an ion-selectivity site in the L-type Ca2+ channel pore Febs Letters. 335: 265-269. PMID 7902817 DOI: 10.1016/0014-5793(93)80743-E  0.358
1992 Nanasi PP, Knilans TK, Varro A, Murphy AM, Fujiki A, Schwartz A, Lathrop DA. Active and passive electrical properties of isolated canine cardiac Purkinje fibers under conditions simulating ischaemia: Effect of diltiazem Pharmacology and Toxicology. 71: 52-56. PMID 1523194 DOI: 10.1111/J.1600-0773.1992.Tb00520.X  0.346
1992 Singer-Lahat D, Lotan I, Itagaki K, Schwartz A, Dascal N. Evidence for the existence of RNA of Ca(2+)-channel alpha 2/delta subunit in Xenopus oocytes. Biochimica Et Biophysica Acta. 1137: 39-44. PMID 1382608 DOI: 10.1016/0167-4889(92)90097-U  0.373
1992 Schwartz A. Molecular and cellular aspects of calcium channel antagonism The American Journal of Cardiology. 70. PMID 1332464 DOI: 10.1016/0002-9149(92)90182-X  0.407
1992 Klöckner U, Itagaki K, Bodi I, Schwartz A. Beta-subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents. Pflugers Archiv : European Journal of Physiology. 420: 413-5. PMID 1317953 DOI: 10.1007/Bf00374479  0.426
1992 Diebold RJ, Koch WJ, Ellinor PT, Wang JJ, Muthuchamy M, Wieczoreck DF, Schwartz A. Mutually exclusive exon splicing of the cardiac calcium channel α1 subunit gene generates developmentally regulated isoforms in the rat heart Proceedings of the National Academy of Sciences of the United States of America. 89: 1497-1501. PMID 1311102 DOI: 10.1073/Pnas.89.4.1497  0.381
1992 Slish DF, Schultz D, Schwartz A. Molecular biology of the calcium antagonist receptor. Hypertension (Dallas, Tex. : 1979). 19: 19-24. PMID 1309719 DOI: 10.1161/01.Hyp.19.1.19  0.392
1992 Lory P, Varadi G, Schwartz A. The beta subunit controls the gating and dihydropyridine sensitivity of the skeletal muscle Ca2+ channel. Biophysical Journal. 63: 1421-4. PMID 1282375 DOI: 10.1016/S0006-3495(92)81705-8  0.62
1992 Lathrop DA, Nánási PP, Varró A, Schwartz A. Ionic basis for OPC-8212 induced increase in action potential duration in isolated rabbit, guinea pig, and human ventricular myocytes Journal of Molecular and Cellular Cardiology. 24: 107. DOI: 10.1016/0022-2828(92)90346-2  0.311
1991 Knilans TK, Lathrop DA, Nanasi PP, Schwartz A, Varro A. Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and V̇(max) British Journal of Pharmacology. 103: 1568-1572. PMID 1884111 DOI: 10.1111/J.1476-5381.1991.Tb09828.X  0.315
1991 Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962 DOI: 10.1073/Pnas.88.3.727  0.393
1991 Varadi G, Lory P, Schultz D, Varadi M, Schwartz A. Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel. Nature. 352: 159-62. PMID 1712427 DOI: 10.1038/352159A0  0.649
1991 Hui A, Ellinor PT, Krizanova O, Wang J, Diebold RJ, Schwartz A. Molecular cloning of multiple subtypes of a novel rat brain isoform of the α1 subunit of the voltage-dependent calcium channel Neuron. 7: 35-44. PMID 1648940 DOI: 10.1016/0896-6273(91)90072-8  0.337
1991 Bazan E, Sole MJ, Schwartz A, Johnson CL. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control. Journal of Molecular and Cellular Cardiology. 23: 111-7. PMID 1648625 DOI: 10.1016/0022-2828(91)90098-7  0.425
1991 Lory P, Varadi G, Schwartz A. Molecular Insights into Regulation of L-Type Ca Channel Function Physiology. 6: 277-281. DOI: 10.1152/Physiologyonline.1991.6.6.277  0.421
1990 Vaghy PL, McKenna E, Itagaki K, Schwartz A. Resolution of the identity of the Ca2(+)-antagonist receptor in skeletal muscle. Trends in Pharmacological Sciences. 9: 398-402. PMID 2855963 DOI: 10.1016/0165-6147(88)90066-1  0.422
1990 Yatani A, Imoto Y, Schwartz A, Brown AM. New positive inotropic agent OPC-8212 modulates single Ca2+ channels in ventricular myocytes of guinea pig. Journal of Cardiovascular Pharmacology. 13: 812-9. PMID 2484074 DOI: 10.1097/00005344-198906000-00002  0.442
1990 Tseng-Crank JC, Tseng GN, Schwartz A, Tanouye MA. Molecular cloning and functional expression of a potassium channel cDNA isolated from a rat cardiac library. Febs Letters. 268: 63-8. PMID 2384173 DOI: 10.1016/0014-5793(90)80973-M  0.398
1990 Mckenna E, Koch WJ, Slish DF, Schwartz A. Toward an understanding of the dihydropyridine-sensitive calcium channel. Biochemical Pharmacology. 39: 1145-1150. PMID 2157442 DOI: 10.1016/0006-2952(90)90255-J  0.38
1989 Schwartz A. Calcium antagonists: Review and perspective on mechanism of action The American Journal of Cardiology. 64. PMID 2554711 DOI: 10.1016/0002-9149(89)90955-7  0.375
1989 Varadi G, Orlowski J, Schwartz A. Developmental regulation of expression of the alpha 1 and alpha 2 subunits mRNAs of the voltage-dependent calcium channel in a differentiating myogenic cell line. Febs Letters. 250: 515-8. PMID 2546810 DOI: 10.1016/0014-5793(89)80787-2  0.366
1989 Slish DF, Engle DB, Varadi G, Lotan I, Singer D, Dascal N, Schwartz A. Evidence for the existence of a cardiac specific isoform of the alpha 1 subunit of the voltage dependent calcium channel. Febs Letters. 250: 509-14. PMID 2546809 DOI: 10.1016/0014-5793(89)80786-0  0.391
1989 Koch WJ, Hui A, Shull GE, Ellinor P, Schwartz A. Characterization of cDNA clones encoding two putative isoforms of the α1 subunit of the dihydropyridine-sensitive voltage-dependent calcium channel isolated from rat brain and rat aorta Febs Letters. 250: 386-388. PMID 2546805 DOI: 10.1016/0014-5793(89)80761-6  0.343
1988 Schwartz A. A view of the latest concepts of the voltage-dependent calcium channel and mechanism of action of calcium channel modulators Cardiovascular Drugs and Therapy. 1: 439-440. PMID 2856471 DOI: 10.1007/Bf02125728  0.39
1988 Dumont L, Williams JS, Vaghy PL, Schwartz A. Characteristics of the phenylalkylamine binding site in canine cardiac sarcolemmal membranes. Basic Research in Cardiology. 83: 369-375. PMID 2847707 DOI: 10.1007/Bf02005822  0.328
1988 Schwartz A, McKenna E, Vaghy PL. Receptors for calcium antagonists. The American Journal of Cardiology. 62: 3G-6G. PMID 2845766 DOI: 10.1016/0002-9149(88)90024-0  0.402
1988 Ellis SB, Williams ME, Ways NR, Brenner R, Sharp AH, Leung AT, Campbell KP, McKenna E, Koch WJ, Hui A, Schwartz A, Harpold MM. Sequence and expression of mRNAs encoding the α1 and α2 subunits of a DHP-sensitive calcium channel Science. 241: 1661-1664. PMID 2458626 DOI: 10.1126/Science.2458626  0.396
1988 Whitmer KR, Williams-Lawson JS, Highsmith RF, Schwartz A. Effect of calcium channel modulators on isolated endothelial cells. Biochemical and Biophysical Research Communications. 154: 591-605. PMID 2456759 DOI: 10.1016/0006-291X(88)90181-7  0.381
1988 Vaghy PL, Itagaki K, Miwa K, McKENNA E, Schwartz A. Mechanism of Action of Calcium Channel Modulator Drugsa Annals of the New York Academy of Sciences. 522: 176-186. PMID 2454052 DOI: 10.1111/J.1749-6632.1988.Tb33353.X  0.375
1987 Miwa K, Schwartz A. Paradoxical augmentation of (-)Bay K 8644-induced calcium influx by nitrendipine. Biochemical and Biophysical Research Communications. 148: 1-8. PMID 2445340 DOI: 10.1016/0006-291X(87)91068-0  0.346
1987 Schwartz A. Studies on mechanisms of calcium channel modulators Journal of Molecular and Cellular Cardiology. 19: 49-62. PMID 2442400 DOI: 10.1016/S0022-2828(87)80004-4  0.376
1987 Walsh KB, Bryant SH, Schwartz A. Suppression of charge movement by calcium antagonists is not related to calcium channel block. Pflugers Archiv : European Journal of Physiology. 409: 217-9. PMID 2441354 DOI: 10.1007/Bf00584775  0.335
1987 Vaghy PL, Williams JS, Schwartz A. Receptor pharmacology of calcium entry blocking agents. The American Journal of Cardiology. 59: 9A-17A. PMID 2433927 DOI: 10.1016/0002-9149(87)90170-6  0.409
1986 Grupp G, Grupp IL, Schwartz A. Reversibility of inotropic effects of ouabain on canine atrial and ventricular tissues. Journal of Molecular and Cellular Cardiology. 17: 1077-84. PMID 4078906 DOI: 10.1016/S0022-2828(85)80123-1  0.324
1986 Lee SW, Wallick ET, Schwartz A, Kranias EG. Influence of protein kinase phosphorylation on isolated sarcolemmal membranes. Journal of Molecular and Cellular Cardiology. 17: 1085-93. PMID 3001320 DOI: 10.1016/S0022-2828(85)80124-3  0.353
1986 Grupp G, Grupp IL, Kojima M, Sperelakis N, Tsuchiya Y, Hosokawa T, Schwartz A. Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and "failing" guinea pig heart preparations. Journal of Cardiovascular Pharmacology. 8: 428-440. PMID 2422485 DOI: 10.1097/00005344-198603000-00029  0.344
1985 Schwartz A, Grupp IL, Grupp G, Williams JS, Vaghy PL. Effects of dihydropyridine calcium channel modulators in the heart: pharmacological and radioligand binding correlations. Biochemical and Biophysical Research Communications. 125: 387-94. PMID 6210085 DOI: 10.1016/S0006-291X(84)80380-0  0.397
1985 Matlib MA, Dubé GP, Millard RW, Lathrop DA, Baik YH, Sakai K, DiSalvo J, Schwartz A. Studies on the mode of action of isosorbide dinitrate: a physiologic and biochemical approach. American Heart Journal. 110: 204-12. PMID 4013996 DOI: 10.1016/0002-8703(85)90488-0  0.306
1985 Schwartz A, Matlib MA, Balwierczak J, Lathrop DA. Pharmacology of calcium antagonists. The American Journal of Cardiology. 55: 3C-7C. PMID 3872055 DOI: 10.1016/0002-9149(85)90798-2  0.392
1985 Shull GE, Schwartz A, Lingrel JB. Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature. 316: 691-5. PMID 2993903 DOI: 10.1038/316691A0  0.308
1985 Lelievre LG, Potter JD, Piascik M, Wallick ET, Schwartz A, Charlemagne D, Geny B. Specific involvement of calmodulin and non-specific effect of tropomyosin in the sensitivity to ouabain of Na+,K+-ATPase in murine plasmocytoma cells. European Journal of Biochemistry. 148: 13-9. PMID 2983988 DOI: 10.1111/J.1432-1033.1985.Tb08800.X  0.411
1985 Balwierczak JL, Schwartz A. Specific binding of [3H]d-cis-diltiazem to cardiac sarcolemma and its inhibition by calcium European Journal of Pharmacology. 116: 193-194. PMID 2932342 DOI: 10.1016/0014-2999(85)90205-5  0.329
1985 Dubé GP, Baik YH, Schwartz A. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. Journal of Cardiovascular Pharmacology. 7: 377-89. PMID 2581094 DOI: 10.1097/00005344-198503000-00025  0.375
1985 Williams JS, Grupp IL, Grupp G, Vaghy PL, Dumont L, Schwartz A, Yatani A, Hamilton S, Brown AM. Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies. Biochemical and Biophysical Research Communications. 131: 13-21. PMID 2412552 DOI: 10.1016/0006-291X(85)91763-2  0.388
1985 Dube GP, Baik YH, Vaghy PL, Schwartz A. Nitrendipine potentiates Bay k 8644-induced contraction of isolated porcine coronary artery: evidence for functionally distinct dihydropyridine receptor subtypes. Biochemical and Biophysical Research Communications. 128: 1295-302. PMID 2408616 DOI: 10.1016/0006-291X(85)91081-2  0.322
1984 Fujiwara H, Ashraf M, Millard RW, Sato S, Schwartz A. Effects of diltiazem, a calcium channel inhibitor, in retarding cellular damage produced during early myocardial ischemia in pigs: a morphometric and ultrastructural analysis. Journal of the American College of Cardiology. 3: 1427-1437. PMID 6715703 DOI: 10.1016/S0735-1097(84)80281-8  0.348
1984 Walsh KB, Bryant SH, Schwartz A. Diltiazem potentiates mechanical activity in mammalian skeletal muscle. Biochemical and Biophysical Research Communications. 122: 1091-6. PMID 6477549 DOI: 10.1016/0006-291X(84)91203-8  0.311
1984 Kranias EG, Nakamura J, Schwartz A. Phospholamban, the regulator of the cardiac sarcoplasmic reticulum calcium pump, does not copurify with the Ca2+-ATPase enzyme. Biochimica Et Biophysica Acta. 749: 62-8. PMID 6315068 DOI: 10.1016/0167-4838(83)90151-6  0.428
1984 Wang T, Tsai LI, Schwartz A. Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum. European Journal of Pharmacology. 100: 253-61. PMID 6234179 DOI: 10.1016/0014-2999(84)90001-3  0.405
1984 Imai K, Wang T, Millard RW, Ashraf M, Kranias EG, Asano G, Grassi de Gende AO, Nagao T, Solaro RJ, Schwartz A. Ischaemia-induced changes in canine cardiac sarcoplasmic reticulum. Cardiovascular Research. 17: 696-709. PMID 6228297 DOI: 10.1093/Cvr/17.11.696  0.428
1984 Vaghy PL, Grupp IL, Grupp G, Balwierczak JL, Williams JS, Schwartz A. Correlation of nitrendipine and Bay k 8644 binding to isolated canine heart sarcolemma with their pharmacological effects on the canine heart. European Journal of Pharmacology. 102: 373-4. PMID 6207033 DOI: 10.1016/0014-2999(84)90273-5  0.336
1984 Vaghy PL, Grupp IL, Grupp G, Schwartz A. Effects of Bay k 8644, a dihydropyridine analog, on [3H]nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect. Circulation Research. 55: 549-53. PMID 6206963 DOI: 10.1161/01.Res.55.4.549  0.349
1984 Grupp G, Grupp I, Dube G, Schwartz A. Effects of dihydropyridine Ca2+ agonist Bay k 8644 on porcine coronary artery and isolated rat hearts Cell Calcium. 5: 313. DOI: 10.1016/0143-4160(84)90136-2  0.341
1983 Nakaya H, Millard RW, Lathrop DA, Gaum WE, Kaplan S, Schwartz A. Flow-independent improvement by diltiazem of ischemia-induced conduction delay in porcine hearts. Journal of the American College of Cardiology. 2: 474-80. PMID 6875111 DOI: 10.1016/S0735-1097(83)80274-5  0.313
1983 Matlib MA, Lee SW, Depover A, Schwartz A. A specific inhibitory action of certain benzothiazepines and benzodiazepines on the sodium-calcium exchange process of heart and brain mitochondria. European Journal of Pharmacology. 89: 327-8. PMID 6873169 DOI: 10.1016/0014-2999(83)90518-6  0.348
1983 DePover A, Lee SW, Matlib MA, Whitmer K, Davis BA, Powell T, Schwartz A. [3H]nimodipine specific binding to cardiac myocytes and subcellular fractions. Biochemical and Biophysical Research Communications. 113: 185-91. PMID 6860335 DOI: 10.1016/0006-291X(83)90449-7  0.301
1983 Rahamathulla PM, Ashraf M, Schwartz A, Benedict J. Effects of diltiazem on anoxic injury in the isolated rat heart. Journal of the American College of Cardiology. 1: 1081-9. PMID 6833646 DOI: 10.1016/S0735-1097(83)80110-7  0.313
1983 Nakaya H, Schwartz A, Millard RW. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared. Circulation Research. 52: 302-11. PMID 6825222 DOI: 10.1161/01.Res.52.3.302  0.412
1983 Matlib MA, Vaghy PL, Epps DE, Schwartz A. Actions of certain calcium channel blockers and calmodulin antagonists on inorganic phosphate-induced swelling and inhibition of oxidative phosphorylation of heart mitochondria. Biochemical Pharmacology. 32: 2622-5. PMID 6615559 DOI: 10.1016/0006-2952(83)90035-7  0.418
1983 DePover A, Grupp IL, Grupp G, Schwartz A. Diltiazem potentiates the negative inotropic action of nimodipine in heart. Biochemical and Biophysical Research Communications. 114: 922-9. PMID 6615515 DOI: 10.1016/0006-291X(83)90648-4  0.314
1983 Matlib MA, Schwartz A. Selective effects of diltiazem, a benzothiazepine calcium channel blocker, and diazepam, and other benzodiazepines on the Na+/Ca2+ exchange carrier system of heart and brain mitochondria. Life Sciences. 32: 2837-2842. PMID 6406780 DOI: 10.1016/0024-3205(83)90319-3  0.426
1983 Lee SW, Schwartz A, Adams RJ, Yamori Y, Whitmer K, Lane LK, Wallick ET. Decrease in Na+,K+-ATPase activity and [3H]ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979). 5: 682-8. PMID 6311739 DOI: 10.1161/01.Hyp.5.5.682  0.368
1983 Matlib MA, Rembert JC, Millard RW, Ashraf M, Rouslin W, Asano G, Greenfield JC, Schwartz A. Mitochondrial function in canine experimental cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 15: 221-32. PMID 6308271 DOI: 10.1016/0022-2828(83)90277-8  0.327
1983 Kranias EG, Samaha FJ, Schwartz A. Mechanism of the stimulation of Ca2+-dependent ATPase of skeletal muscle sarcoplasmic reticulum by protein kinase. Biochimica Et Biophysica Acta. 731: 79-87. PMID 6303413 DOI: 10.1016/0005-2736(83)90400-5  0.383
1983 Kranias EG, Schwartz A, Jungmann RA. Characterization of cyclic 3':5'-amp-dependent protein kinase in sarcoplasmic reticulum and cytosol of canine myocardium. Biochimica Et Biophysica Acta. 709: 28-37. PMID 6295489 DOI: 10.1016/0167-4838(82)90417-4  0.34
1983 Leliévre LG, Piascik MT, Potter JD, Wallick ET, Schwartz A. Involvement of Calmodulin in the Inhibition of Na,K-ATPase by Ouabain Current Topics in Membranes and Transport. 19: 1023-1027. DOI: 10.1016/S0070-2161(08)60670-X  0.363
1983 Whitmer KR, Epps D, Schwartz A. Endogenous Inhibitor of Na,K-ATPase: “Endodigin” Current Topics in Membranes and Transport. 19: 945-950. DOI: 10.1016/S0070-2161(08)60656-5  0.331
1983 Schwartz A, Grupp I, Adams RJ, Powell T, Grupp G, Wallick ET. Pharmacological and Biochemical Studies on the Digitalis Receptor: A Two-Site Hypothesis for Positive Inotropic Action Current Topics in Membranes and Transport. 19: 907-911. DOI: 10.1016/S0070-2161(08)60649-8  0.347
1983 Schwartz A. Positive Inotropic Action of Digitalis and Endogenous Factors: Na,K-ATPase and Positive Inotropy; "Endogenous Glycosides" Current Topics in Membranes and Transport. 19: 825-841. DOI: 10.1016/S0070-2161(08)60642-5  0.361
1982 Vághy PL, Matlib MA, Szekeres L, Schwartz A. Protective effects on verapamil and diltiazem against inorganic phosphate induced impairment of oxidative phosphorylation of isolated heart mitochondria. Biochemical Pharmacology. 30: 2603-10. PMID 7306212 DOI: 10.1016/0006-2952(81)90588-8  0.301
1982 Ashraf M, Onda M, Hirohata Y, Schwartz A. Therapeutic effect of diltiazem on myocardial cell injury during the calcium paradox. Journal of Molecular and Cellular Cardiology. 14: 323-7. PMID 7131565 DOI: 10.1016/0022-2828(82)90247-4  0.373
1982 Lathrop DA, Valle-Aguilera JR, Millard RW, Gaum WE, Hannon DW, Francis PD, Nakaya H, Schwartz A. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue. The American Journal of Cardiology. 49: 613-20. PMID 7058769 DOI: 10.1016/S0002-9149(82)80020-9  0.347
1982 Schwartz A. Regulation of calcium in cardiac muscle. Annals of the New York Academy of Sciences. 382: 183-9. PMID 6952802 DOI: 10.1111/J.1749-6632.1982.Tb55216.X  0.352
1982 DePover A, Matlib MA, Lee SW, Dubé GP, Grupp IL, Grupp G, Schwartz A. Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem Biochemical and Biophysical Research Communications. 108: 110-117. PMID 6293474 DOI: 10.1016/0006-291X(82)91838-1  0.365
1982 Adams RJ, Schwartz A, Grupp G, Grupp I, Lee S, Wallick ET, Powell T, Twist VW, Gathiram P. High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium Nature. 296: 167-169. PMID 6278317 DOI: 10.1038/296167A0  0.361
1982 Millard RW, Lathrop DA, Grupp G, Ashraf M, Grupp IL, Schwartz A. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. The American Journal of Cardiology. 49: 499-506. PMID 6277175 DOI: 10.1016/S0002-9149(82)80002-7  0.402
1982 Bilezikjian LM, Kranias EG, Potter JD, Schwartz A. Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase. Circulation Research. 49: 1356-62. PMID 6273007 DOI: 10.1161/01.Res.49.6.1356  0.331
1982 Epps DE, Mandel F, Schwartz A. The alteration of rabbit skeletal sarcoplasmic reticulum function by N-acylethanolamine, a lipid associated with myocardial infarction Cell Calcium. 3: 531-543. PMID 6219743 DOI: 10.1016/0143-4160(82)90043-4  0.371
1982 Mandel F, Kranias EG, Grassi de Gende A, Sumida M, Schwartz A. The effect of pH on the transient-state kinetics of Ca2+-Mg2+-ATPase of cardiac sarcoplasmic reticulum. A comparison with skeletal sarcoplasmic reticulum. Circulation Research. 50: 310-7. PMID 6120049 DOI: 10.1161/01.Res.50.2.310  0.361
1981 Wang T, Gende AOGd, Tsai L, Schwartz A. Influence of monovalent cations on the Ca2+-ATPase of sarcoplasmic reticulum isolated from rabbit skeletal and dog cardiac muscles. An interpretation of transient-state kinetic data. Biochimica Et Biophysica Acta. 637: 523-529. PMID 6456766 DOI: 10.1016/0005-2728(81)90059-1  0.417
1981 Collins JH, Kranias EG, Reeves AS, Bilezikjian LM, Schwartz A. Isolation of phospholamban and a second proteolipid component from canine cardiac sarcoplasmic reticulum. Biochemical and Biophysical Research Communications. 99: 796-803. PMID 6454414 DOI: 10.1016/0006-291X(81)91235-3  0.359
1981 Ball WJ, Tse-Eng D, Wallick ET, Bilezikian JP, Schwartz A, Butler VP. Effect of quinidine on the digoxin receptor in vitro. The Journal of Clinical Investigation. 68: 1065-74. PMID 6270193 DOI: 10.1172/Jci110329  0.336
1981 Kranias EG, Bilezikjian LM, Potter JD, Piascik MT, Schwartz A. The role of calmodulin in regulation of cardiac sarcoplasmic reticulum phosphorylation. Annals of the New York Academy of Sciences. 356: 279-91. PMID 6263150 DOI: 10.1111/J.1749-6632.1980.Tb29618.X  0.332
1981 Kranias EG, Mandel F, Wang T, Schwartz A. Mechanism of the stimulation of calcium ion dependent adenosine triphosphatase of cardiac sarcoplasmic reticulum by adenosine 3',5'-monophosphate dependent protein kinase. Biochemistry. 19: 5434-9. PMID 6255993 DOI: 10.1021/Bi00564A044  0.411
1981 Grupp G, Grupp IL, Johnson CL, Matlib MA, Rouslin W, Schwartz A, Wallick ET, Wang T, Wisler P. Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity. British Journal of Pharmacology. 70: 429-42. PMID 6254599 DOI: 10.1111/J.1476-5381.1980.Tb08721.X  0.31
1981 Vághy PL, Matlib MA, Schwartz A. Phosphate induced swelling, inhibition and partial uncoupling of oxidative phosphorylation in heart mitochondria in the absence of external calcium and the presence of EGTA. Biochemical and Biophysical Research Communications. 100: 37-44. PMID 6167258 DOI: 10.1016/S0006-291X(81)80059-9  0.316
1980 Grupp G, Grupp I, Schwartz A. Lack of effect of neuraminidase on responses of isolated guinea-pig heart preparations to ouabain. Journal of Molecular and Cellular Cardiology. 12: 1471-1474. PMID 7205961 DOI: 10.1016/0022-2828(80)90130-3  0.303
1980 Schwartz A, Adams RJ, Grupp I, Grupp G, Holroyde MJ, Millard RW, Solaro RJ, Wallick ET. Effects of vanadate on myocardial function Basic Research in Cardiology. 75: 444-451. PMID 6449925 DOI: 10.1007/Bf01908409  0.302
1980 Wallick ET, Pitts BJ, Lane LK, Schwartz A. A kinetic comparison of cardiac glycoside interactions with Na+,K+-ATPases from skeletal and cardiac muscle and from kidney. Archives of Biochemistry and Biophysics. 202: 442-9. PMID 6257168 DOI: 10.1016/0003-9861(80)90448-8  0.331
1980 Schwartz A, Adams RJ, Ball WJ, Collins JH, Gupte SS, Lane LK, Reeves AS, Wallick ET. Structure, function and regulation of Na-K-ATPase. International Journal of Biochemistry. 12: 287-293. PMID 6249660 DOI: 10.1016/0020-711X(80)90086-5  0.312
1980 Adams RJ, Schwartz A. Comparative mechanisms for contraction of cardiac and skeletal muscle Chest. 78: 123-139. PMID 6249549 DOI: 10.1378/Chest.78.1_Supplement.123  0.378
1980 Asano G, Ashraf M, Schwartz A. Localization of Na-K-ATPase in guinea-pig myocardium. Journal of Molecular and Cellular Cardiology. 12: 257-66. PMID 6246247 DOI: 10.1016/0022-2828(80)90039-5  0.318
1980 Galani-Kranias E, Bick R, Schwartz A. Phosphorylation of a 100 000 dalton component and its relationship to calcium transport in sarcoplasmic reticulum from rabbit skeletal muscle. Biochimica Et Biophysica Acta. 628: 438-450. PMID 6245711 DOI: 10.1016/0304-4165(80)90393-1  0.343
1980 Kranias EG, Mandel F, Schwartz A. Involvement of cAMP-dependent protein kinase and pH on the regulation of cardiac sarcoplasmic reticulum. Biochemical and Biophysical Research Communications. 92: 1370-6. PMID 6245652 DOI: 10.1016/0006-291X(80)90437-4  0.352
1980 Solaro RJ, Holroyde MJ, Wang T, Matlib MA, Grupp I, Grupp G, Schwartz A. Effects of vanadate on biochemical and contractile properties of rabbit hearts. Journal of Cardiovascular Pharmacology. 2: 445-52. PMID 6156342 DOI: 10.1097/00005344-198007000-00011  0.323
1980 Wang T, Tsai LI, Solaro RJ, Grassi de Gende AO, Schwartz A. Effects of potassium on vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase from dog cardiac and rabbit skeletal muscle. Biochemical and Biophysical Research Communications. 91: 356-61. PMID 160227 DOI: 10.1016/0006-291X(79)90626-0  0.401
1979 Gervais A, Busch U, Wood JM, Schwartz A. Effect of a toxic in vivo dose of ouabain on guinea-pig heart mitochondria. Journal of Molecular and Cellular Cardiology. 10: 1003-15. PMID 722798 DOI: 10.1016/0022-2828(78)90397-8  0.342
1979 Adams RJ, Pitts BJ, Woods JM, Gende OA, Wallick ET, Schwartz A. Effect of palmitylcarnitine on ouabain binding to Na, K-ATPase. Journal of Molecular and Cellular Cardiology. 11: 941-59. PMID 230355 DOI: 10.1016/0022-2828(79)90386-9  0.359
1979 Grupp G, Grupp I, Johnson CL, Wallick ET, Schwartz A. Effect of vanadate on cardiac contraction and adenylate cyclase. Biochemical and Biophysical Research Communications. 88: 440-7. PMID 223558 DOI: 10.1016/0006-291X(79)92068-0  0.321
1979 Thomas R, Allen J, Pitts BJ, Schwartz A. Cardenolide analogs. An explanation for the usual properties of AY 22241. European Journal of Pharmacology. 53: 227-37. PMID 215418 DOI: 10.1016/0014-2999(79)90128-6  0.314
1979 Matlib MA, Rouslin W, Kraft G, Berner P, Schwartz A. On the existence of two populations of mitochondria in a single organ. Respiration, calcium transport and enzyme activities. Biochemical and Biophysical Research Communications. 84: 482-8. PMID 214079 DOI: 10.1016/0006-291X(78)90194-8  0.321
1979 Gillette PC, Pinsky WW, Lewis RM, Bornet EP, Wood JM, Entman ML, Schwartz A. Myocardial depression after elective ischemic arrest The Journal of Thoracic and Cardiovascular Surgery. 77: 608-618. DOI: 10.1016/S0022-5223(19)38269-8  0.332
1978 Wood JM, Schwartz A. Effects of ouabain on calcium-45 flux in guinea pig cardiac tissue Journal of Molecular and Cellular Cardiology. 10: 137-144. PMID 633378 DOI: 10.1016/0022-2828(78)90038-X  0.361
1978 Sumida M, Schwartz A, Froehlich JP. Preliminary observations of pre-steady-state kinetics of phosphorylation and dephosphorylation of sarcoplasmic reticulum (SR) membranes from heart and skeletal muscle Annals of the New York Academy of Sciences. 307: 228. PMID 280265 DOI: 10.1111/J.1749-6632.1978.Tb41948.X  0.312
1978 Michael L, Pitts BJ, Schwartz A. Is pump stimulation associated with positive inotropy of the heart? Science (New York, N.Y.). 200: 1287-9. PMID 149369 DOI: 10.1126/Science.149369  0.316
1978 Lane LK, Anner BM, Wallick ET, Ray MV, Schwartz A. Effect of phospholipase A treatment on the partial reactions of and ouabain binding to a purified sodium and potassium activated adenosine triphosphatase. Biochemical Pharmacology. 27: 225-231. PMID 146495 DOI: 10.1016/0006-2952(78)90305-2  0.315
1978 Sumida M, Wang T, Mandel F, Froehlich JP, Schwartz A. Transient kinetics of Ca2+ transport of sarcoplasmic reticulum. A comparison of cardiac and skeletal muscle. Journal of Biological Chemistry. 253: 8772-8777. DOI: 10.1016/B978-0-12-511050-1.50016-8  0.394
1977 Ezrailson EG, Potter JD, Michael L, Schwartz A. Positive inotropy induced by ouabain, by increased frequency, by X537A (RO2-2985), by calcium and by isoproterenol: the lack of correlation with phosphorylation of TnI. Journal of Molecular and Cellular Cardiology. 9: 693-8. PMID 903977 DOI: 10.1016/S0022-2828(77)80364-7  0.333
1977 Bornet EP, Wood JM, Goldstein MA, Entman ML, Lewis RM, Dunn FA, Schwartz A. Physiological, biochemical, and morphological characteristics of myocardial anoxia: the use of a semi-perfusion canine preparation. Cardiovascular Research. 11: 568-75. PMID 603880 DOI: 10.1093/Cvr/11.6.568  0.356
1977 Entman M, Bornet E, Vanwinkle W, Goldstein M, Schwartz A. Association of glycogenolysis with cardiac sarcoplasmic recticulum: II. Effect of glycogen depletion, deoxycholate solubilization and cardiac ischemia: Evidence for a phosphorylase kinase membrane complex Journal of Molecular and Cellular Cardiology. 9: 515-528. PMID 408501 DOI: 10.1016/S0022-2828(77)80367-2  0.353
1977 Reddy YS, Pitts BJ, Schwartz A. Cyclic AMP-dependent and independent protein kinase phosphorylation of canine cardiac myosin light chains. Journal of Molecular and Cellular Cardiology. 9: 501-13. PMID 197241 DOI: 10.1016/S0022-2828(77)80365-9  0.309
1977 Bornet EP, Entman ML, Van Winkle WB, Schwartz A, Lehotay DC, Levey GS. Cyclic AMP modulation of calcium accumulation by sarcoplasmic reticulum from fast skeletal muscle. Biochimica Et Biophysica Acta. 468: 188-93. PMID 195607 DOI: 10.1016/0005-2736(77)90113-4  0.327
1977 Pitts BJ, Wallick ET, Van Winkle WB, Allen JC, Schwartz A. On the lack of inotropy of cardiac glycosides on skeletal muscle: a comparison of Na+, K+-ATPases from skeletal and cardiac muscle. Archives of Biochemistry and Biophysics. 184: 431-40. PMID 145824 DOI: 10.1016/0003-9861(77)90453-2  0.347
1977 Wang T, Lindenmayer GE, Schwartz A. Steady-state kinetic study of magnesium and ATP effects on ligand affinity and catalytic activity of sheep kidney sodium, potassium-adenosinetriphosphatase. Biochimica Et Biophysica Acta. 484: 140-60. PMID 142515 DOI: 10.1016/0005-2744(77)90120-6  0.317
1977 Wood JM, Bush B, Pitts BJ, Schwartz A. Inhibition of bovine heart Na+, K+-ATPase by palmitylcarnitine and palmityl-CoA. Biochemical and Biophysical Research Communications. 74: 677-84. PMID 138422 DOI: 10.1016/0006-291X(77)90356-4  0.309
1977 Gervais A, Lane LK, Anner BM, Lindenmayer GE, Schwartz A. A possible molecular mechanism of the action of digitalis: ouabain action on calcium binding to sites associated with a purified sodium-potassium-activated adenosine triphosphatase from kidney. Circulation Research. 40: 8-14. PMID 137087 DOI: 10.1161/01.Res.40.1.8  0.368
1977 Kaniike K, Pitts BJ, Schwartz A. Cyclic AMP-dependent protein kinase phosphorylation of cardiac (Na+ + K+)-ATPases. Effect on calcium binding. Biochimica Et Biophysica Acta. 483: 294-302. PMID 19066 DOI: 10.1016/0005-2744(77)90057-2  0.375
1977 Schwartz A, Endman M, Ezrailson E, Lehotay D, Leyey G. Possible cyclic nucleotide regulation of calcium mediating myocardial contraction. Science. 195: 982-990. PMID 14399 DOI: 10.1126/Science.14399  0.346
1976 Entman ML, Goldstein MA, Schwartz A. The cardiac sarcoplasmic reticulum - glycogenolytic complex, an internal beta adrenergic receptor. Life Sciences. 19: 1623-1630. PMID 187884 DOI: 10.1016/0024-3205(76)90066-7  0.344
1976 Reddy YS, Wyborny L, Lewis RM, Schwartz A. Biochemical and morphological correlates of cardiac ischaemia: Contractile proteins. Cardiovascular Research. 10: 129-35. PMID 130206 DOI: 10.1093/Cvr/10.1.129  0.308
1976 Schwartz A. Cellular and molecular mechanisms involved in cardiac cell function: effects of an antibiotic ionophore Acta Medica Scandinavica. 199: 71-82. PMID 130059 DOI: 10.1111/J.0954-6820.1976.Tb05869.X  0.337
1976 Schwartz A, Entman ML, Kaniike K, Lane LK, Winkle WBV, Bornet EP. The rate of calcium uptake into sarcoplasmic reticulum of cardiac muscle and skeletal muscle. Effects of cyclic AMP-dependent protein kinase and phosphorylase b kinase. Biochimica Et Biophysica Acta. 426: 57-72. PMID 2325 DOI: 10.1016/0005-2736(76)90429-6  0.308
1975 Allen JC, Schwartz A. Na+, K+-ATPase, the transport enzyme: evidence for its proposed role as pharmacologic receptor for cardiac glycosides. Annals of the New York Academy of Sciences. 242: 646-57. PMID 4279612 DOI: 10.1111/J.1749-6632.1974.Tb19123.X  0.31
1975 Pitts BJ, Schwartz A. Improved purification and partial characterization of (Na+, K+)-ATPase from cardiac muscle. Biochimica Et Biophysica Acta. 401: 184-95. PMID 125612 DOI: 10.1016/0005-2736(75)90303-X  0.315
1975 Lindenmayer GE, Schwartz A. A kinetic characterization of calcium on (Na+ + K+)-ATPase and its potential role as a link between extracellular and intracellular events: hypothesis for digitalis-induced inotropism. Journal of Molecular and Cellular Cardiology. 7: 591-612. PMID 124785 DOI: 10.1016/0022-2828(75)90117-0  0.375
1974 Goldstein MA, Sordahl LA, Schwartz A. Ultrastructural analysis of left ventricular hypertrophy in rabbits. Journal of Molecular and Cellular Cardiology. 6: 265-273. PMID 4837897 DOI: 10.1016/0022-2828(74)90055-8  0.332
1974 McCANS JL, Lindenmayer GE, Munson RG, Evans RW, Schwartz A. A Dissociation of Positive Staircase (Bowditch) from Ouabain-Induced Positive Inotropism Circulation Research. 35: 439-447. PMID 4424268 DOI: 10.1161/01.Res.35.3.439  0.335
1974 Schwartz A. Ouabain induced inhibition of cardiac (Na+ + K+)ATPase and the positive inotropic response Annals of the New York Academy of Sciences. 683. PMID 4279615 DOI: 10.1111/J.1749-6632.1974.Tb19126.X  0.326
1974 Schwartz A, Lindenmayer GE, Allen JC, McCans JL. THE NATURE OF THE CARDIAC GLYCOSIDE ENZYME COMPLEX: MECHANISM AND KINETICS OF BINDING AND DISSOCIATION USING A HIGH-ACTIVITY HEART Na+, K+-ATPase* Annals of the New York Academy of Sciences. 242: 577-597. PMID 4279607 DOI: 10.1111/J.1749-6632.1974.Tb19119.X  0.355
1974 Schwartz A, Lewis RM, Hanley HG, Munson RG, Dial FD, Ray MV. Hemodynamic and biochemical effects of a new positive inotropic agent. Antibiotic ionophore RO 2-2985. Circulation Research. 34: 102-11. PMID 4148942 DOI: 10.1161/01.Res.40.4.102  0.334
1973 Wood JM, Sordahl LA, Lewis RM, Schwartz A. Effect of chronic myocardial ischemia on the activity of carnitine palmitylcoenzyme A transferase of isolated canine heart mitochondria Circulation Research. 32: 340-347. PMID 4691339 DOI: 10.1161/01.Res.32.3.340  0.315
1973 Reddy YS, Ballard D, Giri NY, Schwartz A. Phosphorylation of cardiac native tropomyosin and troponin: inhibitory effect of actomyosin and possible presence of endogenous myofibrillar-located cyclic-AMP-dependent protein kinase. Journal of Molecular and Cellular Cardiology. 5: 461-464. PMID 4357624 DOI: 10.1016/0022-2828(73)90016-3  0.344
1973 Pitts BJ, Lane LK, Schwartz A. Nature of the transport ATPase-digitalis complex. VI. Purification of and ouabain binding to a highly active cardiac Na+, K+-ATPase. Biochemical and Biophysical Research Communications. 53: 1060-6. PMID 4356048 DOI: 10.1016/0006-291X(73)90572-X  0.332
1973 Schwartz A, Sordahl LA, Entman ML, Allen JC, Reddy YS, Goldstein MA, Luchi RJ, Wyborny LE. Abnormal biochemistry in myocardial failure. The American Journal of Cardiology. 32: 407-22. PMID 4354110 DOI: 10.1016/S0002-9149(73)80031-1  0.397
1973 Vargo TA, Wood JM, Schwartz A. An effect of ouabain on isolated heart tissue from cardiomyopathic Syrian hamsters. Journal of Molecular and Cellular Cardiology. 4: 495-506. PMID 4343537 DOI: 10.1016/0022-2828(72)90106-X  0.323
1973 Inagaki C, Martinez-Maldonado M, Schwartz A. Some in vivo and in vitro effects of ethacrynic acid on renal Na+,K+ -ATPase. Archives of Biochemistry and Biophysics. 158: 421-34. PMID 4269670 DOI: 10.1016/0003-9861(73)90639-5  0.316
1973 Schwartz A, Wood JM, Allen JC, Bornet EP, Entman ML, Goldstein MA, Sordahl LA, Suzuki M, Lewis RM. Biochemical and morphologic correlates of cardiac ischemia American Journal of Cardiology. 32: 46-61. PMID 4268278 DOI: 10.1016/S0002-9149(73)80085-2  0.361
1972 Besch HR, Schwartz A. Initial calcium binding rates of canine cardiac relaxing system (sarcoplasmic reticulum fragments) determined by stopped-flow spectrophotometry. Biochemical and Biophysical Research Communications. 45: 286-92. PMID 5160717 DOI: 10.1016/0006-291X(71)90815-1  0.398
1972 Entman ML, Bornet EP, Schwartz A. Phasic components of calcium binding and release by canine cardiac relaxing system (sarcoplasmic reticulum fragments). Journal of Molecular and Cellular Cardiology. 4: 155-69. PMID 5027350 DOI: 10.1016/0022-2828(72)90072-7  0.349
1972 Sordahl LA, Crow CA, Kraft GH, Schwartz A. Some ultrastructural and biochemical aspects of heart mitochondria associated with development: Fetal and cardiomyopathic tissue Journal of Molecular and Cellular Cardiology. 4: 1-10. PMID 5022516 DOI: 10.1016/0022-2828(72)90092-2  0.307
1972 Nakamaru Y, Schwartz A. The influence of hydrogen ion concentration on calcium binding and release by skeletal muscle sarcoplasmic reticulum. The Journal of General Physiology. 59: 22-32. PMID 5007263 DOI: 10.1085/Jgp.59.1.22  0.319
1972 Entman ML, Allen JC, Bornet EP, Gillette PC, Wallick ET, Schwartz A. Mechanisms of calcium accumulation and transport in cardiac relaxing system (sarcoplasmic reticulum membranes): effects of Verapamil, D-600, X537A and A23187. Journal of Molecular and Cellular Cardiology. 4: 681-687. PMID 4652932 DOI: 10.1016/0022-2828(72)90121-6  0.372
1972 Nagai K, Lindenmayer GE, Schwartz A. A fluorescence probe analysis of possible conformational changes in the sodium, potassium-adenosine triphosphatase of synoptic membranes induced by nucleotide, sodium, potassium and ouabain☆ Archives of Biochemistry and Biophysics. 152: 329-338. PMID 4262872 DOI: 10.1016/0003-9861(72)90222-6  0.326
1972 Entman ML, Allen JC, Schwartz A. Calcium-ouabain interaction in a "microsomal" membrane fraction containing Na+, K+-ATPase activity and calcium binding activity. Journal of Molecular and Cellular Cardiology. 4: 435-41. PMID 4262253 DOI: 10.1016/0022-2828(72)90089-2  0.364
1971 Lindenmayer GE, Harigaya S, Bajusz E, Schwartz A. Oxidative phosphorylation and calcium transport of mitochondria isolated from cardiomyopathic hamster hearts. Journal of Molecular and Cellular Cardiology. 1: 249-59. PMID 5519939 DOI: 10.1016/0022-2828(70)90005-2  0.336
1971 Nakamaru Y, Schwartz A. Possible control of intracellular calcium metabolism by [H+]: sarcoplasmic reticulum of skeletal and cardiac muscle. Biochemical and Biophysical Research Communications. 41: 830-6. PMID 5482266 DOI: 10.1016/0006-291X(70)90157-9  0.355
1971 Allen JC, Schwartz A. Effects of potassium, temperature and time on ouabain interaction with the cardiac Na+, K+-ATPase: further evidence supporting an allosteric site. Journal of Molecular and Cellular Cardiology. 1: 39-45. PMID 4255499 DOI: 10.1016/0022-2828(70)90027-1  0.327
1971 Allen JC, Martinez-Maldonado M, Eknoyan G, Suki WN, Schwartz A. Relation between digitalis binding in vivo and inhibition of sodium, potassium-adenosine triphosphatase in canine kidney. Biochemical Pharmacology. 20: 73-80. PMID 4255110 DOI: 10.1016/0006-2952(71)90473-4  0.308
1971 Lindenmayer GE, Sordahl LA, Harigaya S, Allen JC, Besch HR, Schwartz A. Some biochemical studies on subcellular systems isolated from fresh recipient human cardiac tissue obtained during transplantation. The American Journal of Cardiology. 27: 277-83. PMID 4250860 DOI: 10.1016/0002-9149(71)90303-1  0.365
1971 Nakamaru Y, Schwartz A. Adenosine triphosphate-dependent calcium-binding vesicles; magnesium, calcium adenosine triphosphatase and sodium, potassium adenosine triphosphatase: Distributions in dog brain☆ Archives of Biochemistry and Biophysics. 144: 16-29. DOI: 10.1016/0003-9861(71)90451-6  0.41
1970 McCollum WB, Crow C, Harigaya S, Bajusz E, Schwartz A. Calcium binding by cardiac relaxing system isolated from myopathic syrian hamsters (strains 14.6, 82.62 and 40.54) Journal of Molecular and Cellular Cardiology. 1. PMID 5520077 DOI: 10.1016/0022-2828(70)90041-6  0.331
1970 Harigaya S, Schwartz A. Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Membrane vesicles (relaxing system) and mitochondria. Circulation Research. 25: 781-94. PMID 5364651 DOI: 10.1161/01.Res.25.6.781  0.379
1970 Allen JC, Lindenmayer GE, Schwartz A. An allosteric explanation for ouabain-lnduced time-dependent inhibition of sodium, potassium-adenosine triphosphatase Archives of Biochemistry and Biophysics. 141: 322-328. PMID 4249246 DOI: 10.1016/0003-9861(70)90138-4  0.326
1970 Lindenmayer GE, Schwartz A. Conformational changes induced in Na+, K+-ATPase by ouabain through a K+-sensitive reaction: Kinetic and spectroscopic studies Archives of Biochemistry and Biophysics. 140: 371-378. PMID 4248630 DOI: 10.1016/0003-9861(70)90078-0  0.307
Show low-probability matches.